Hyperkalemia

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019
Google Plus
LinkedIn

Hyperkalemia in Patients With Chronic Renal Failure

Stephen L Seliger
Nephrol Dial Transplant . 2019 Dec 1;34(Suppl 3):iii12-iii18
Google Plus
LinkedIn

Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age

J. Ariana Noel, MD; Sarah E. Bota, BSc; William Petrcich, MSc; et al
JAMA Intern Med . 2019 Jun 10;179(8):1025-1033
Google Plus
LinkedIn

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia

Bruce S. Spinowitz, Steven Fishbane, Pablo E. Pergola, Simon D. Roger, Edgar V. Lerma, Javed Butler, Stephan von Haehling, Scott H. Adler, June Zhao, Bhupinder Singh, Philip T. Lavin, Peter A. McCullough, Mikhail Kosiborod, David K. Packham
Clin J Am Soc Nephrol . 2019 Jun 7;14(6):798-809
Google Plus
LinkedIn

Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia

Meaney CJ et al
Pharmacotherapy . 2017 Apr;37(4):401-411. doi: 10.1002/phar.1906. Epub 2017 Mar 10
Google Plus
LinkedIn

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors

Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators
N Engl J Med. 2015 Jan 15;372(3):211-21
Google Plus
LinkedIn

Sodium zirconium cyclosilicate in hyperkalemia

Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B
N Engl J Med. 2015 Jan 15;372(3):222-31
Google Plus
LinkedIn

ukidneyisup